These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29977284)

  • 1. Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen.
    Lee HS; Jeon SW; Nomura S; Seto Y; Kwon YH; Nam SY; Ishibashi Y; Ohtsu H; Ohmoto Y; Yang HM
    Gastroenterol Res Pract; 2018; 2018():1024074. PubMed ID: 29977284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.
    Aikou S; Ohmoto Y; Gunji T; Matsuhashi N; Ohtsu H; Miura H; Kubota K; Yamagata Y; Seto Y; Nakajima A; Goldenring JR; Kaminishi M; Nomura S
    Gastroenterology; 2011 Sep; 141(3):837-845.e1-7. PubMed ID: 21699780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.
    Lee JY; Park KS; Lee HG; Baek WK; Cho KB; Lee YJ; Lee YS; Ryu SW
    Clin Exp Med; 2017 Aug; 17(3):403-410. PubMed ID: 27154568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker.
    Kaise M; Miwa J; Fujimoto A; Tashiro J; Tagami D; Sano H; Ohmoto Y
    Gastric Cancer; 2013 Jul; 16(3):329-37. PubMed ID: 22907485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk.
    Kaise M; Miwa J; Tashiro J; Ohmoto Y; Morimoto S; Kato M; Urashima M; Ikegami M; Tajiri H
    J Gastroenterol; 2011 Jun; 46(6):736-45. PubMed ID: 21455714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China.
    Huang Z; Zhang X; Lu H; Wu L; Wang D; Zhang Q; Ding H
    BMC Gastroenterol; 2014 Apr; 14():74. PubMed ID: 24720760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer.
    Jahan R; Ganguly K; Smith LM; Atri P; Carmicheal J; Sheinin Y; Rachagani S; Natarajan G; Brand RE; Macha MA; Grandgenett PM; Kaur S; Batra SK
    EBioMedicine; 2019 Apr; 42():375-385. PubMed ID: 30956167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Level of Trefoil Factor 2 can Predict the Extent of Gastric Spasmolytic Polypeptide-Expressing Metaplasia in the H. pylori-Infected Gastric Cancer Relatives.
    Kuo HY; Chang WL; Yeh YC; Tsai YC; Wu CT; Cheng HC; Yang HB; Lu CC; Sheu BS
    Helicobacter; 2017 Feb; 22(1):. PubMed ID: 27220894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers.
    Xiao L; Liu YP; Xiao CX; Ren JL; Guleng B
    BMC Clin Pathol; 2014; 14():26. PubMed ID: 25031551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
    Kwon Y; Jeon S; Nam S; Shin I
    Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.
    Ishibashi Y; Ohtsu H; Ikemura M; Kikuchi Y; Niwa T; Nishioka K; Uchida Y; Miura H; Aikou S; Gunji T; Matsuhashi N; Ohmoto Y; Sasaki T; Seto Y; Ogawa T; Tada K; Nomura S
    Sci Rep; 2017 Jul; 7(1):4846. PubMed ID: 28687783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early gastric cancer: detection and endoscopic treatment.
    Costamagna G; Cesaro P
    Ann Ital Chir; 2012; 83(3):183-91. PubMed ID: 22595729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer screening using the serum pepsinogen test method.
    Miki K
    Gastric Cancer; 2006; 9(4):245-53. PubMed ID: 17235625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of gastric cancer screening using the serum pepsinogen test method.
    Miki K; Morita M; Sasajima M; Hoshina R; Kanda E; Urita Y
    Am J Gastroenterol; 2003 Apr; 98(4):735-9. PubMed ID: 12738449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm.
    Cha JH; Jang JS
    Korean J Intern Med; 2020 Apr; 35(3):550-558. PubMed ID: 30400679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value evaluation of trefoil factors family 3 for the early detection of colorectal cancer.
    Xie H; Guo JH; An WM; Tian ST; Yu HP; Yang XL; Wang HM; Guo Z
    World J Gastroenterol; 2017 Mar; 23(12):2159-2167. PubMed ID: 28405143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of trefoil factors are increased in patients with advanced prostate cancer.
    Vestergaard EM; Borre M; Poulsen SS; Nexø E; Tørring N
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):807-12. PubMed ID: 16467092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.
    Qu Y; Yang Y; Ma D; Xiao W
    Oncol Rep; 2012 Apr; 27(4):1277-83. PubMed ID: 22246423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen.
    Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Nishida J
    Anticancer Res; 2015 Dec; 35(12):6765-71. PubMed ID: 26637894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.